SCHEMBL13451653

SCHEMBL13451653

CCCC(O)OC[C@@H](O)COC

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.35
HSD17B10 Q99714 1/20 0.32
MAPT P10636 1/20 0.32
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1206579 0.80 USP2 (0.44) TDP1USP2
SCHEMBL135974 0.79
SCHEMBL12020546 0.79
SCHEMBL11074667 0.77 TDP1 (0.50) TDP1HSD17B10MAPT
SCHEMBL55052 0.75
SCHEMBL11654598 0.75 TDP1 (0.39) TDP1HSD17B10
SCHEMBL8865513 0.75
SCHEMBL15923451 0.74 TDP1 (0.39) TDP1HSD17B10
SCHEMBL106780 0.74
SCHEMBL20295231 0.73 HSD17B10 (0.34) HSD17B10MAPTUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1351973-B1 CONJUGATES OF IMMUNE CELL SPECIFIC MACROLIDE COMPOUNDS WITH ANTI-INFLAMMATORY COMPOUNDS FOR IMPROVED CELLULAR TARGETING OF ANTI-INFLAMMATORY THERAPY GLAXOSMITHKLINE ZAGREB (HR) 2010-03-31 EP disclosed